Home DailyMed 733ea2de-94de-457a-a7e7-cfa27e2ad28f National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 02:03:13 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A074501-001 NADOLOL NADOLOL 20MG TABLET / ORAL AB 1995-11-09 A074501-002 NADOLOL NADOLOL 40MG TABLET / ORAL AB 1995-11-09 A074501-003 NADOLOL NADOLOL 80MG TABLET / ORAL AB 1995-11-09
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 4 of 4 · 129 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-09-29 23:25 UTC 2022-09 A074501-001 NADOLOL 20MG TABLET / ORAL AB 1995-11-09 e64feba35796…2022-09-29 23:25 UTC 2022-09 A074501-002 NADOLOL 40MG TABLET / ORAL AB 1995-11-09 e64feba35796…2022-09-29 23:25 UTC 2022-09 A074501-003 NADOLOL 80MG TABLET / ORAL AB 1995-11-09 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A074501-001 NADOLOL 20MG TABLET / ORAL AB 1995-11-09 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A074501-002 NADOLOL 40MG TABLET / ORAL AB 1995-11-09 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A074501-003 NADOLOL 80MG TABLET / ORAL AB 1995-11-09 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A074501-001 NADOLOL 20MG TABLET / ORAL AB 1995-11-09 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A074501-002 NADOLOL 40MG TABLET / ORAL AB 1995-11-09 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A074501-003 NADOLOL 80MG TABLET / ORAL AB 1995-11-09 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 129 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.